Acro Biomedical (ACBM) Leases (2019 - 2025)
Acro Biomedical (ACBM) has 7 years of Leases data on record, last reported at $13651.0 in Q2 2025.
- For Q2 2025, Leases fell 65.66% year-over-year to $13651.0; the TTM value through Jun 2025 reached $13651.0, down 65.66%, while the annual FY2024 figure was $26898.0, 48.5% down from the prior year.
- Leases reached $13651.0 in Q2 2025 per ACBM's latest filing, down from $20324.0 in the prior quarter.
- Across five years, Leases topped out at $52233.0 in Q4 2023 and bottomed at $6268.0 in Q3 2021.
- Average Leases over 5 years is $27734.6, with a median of $26308.5 recorded in 2022.
- Peak YoY movement for Leases: plummeted 79.6% in 2023, then soared 411.42% in 2024.
- A 5-year view of Leases shows it stood at $50432.0 in 2021, then tumbled by 49.0% to $25719.0 in 2022, then surged by 103.09% to $52233.0 in 2023, then plummeted by 48.5% to $26898.0 in 2024, then plummeted by 49.25% to $13651.0 in 2025.
- Per Business Quant database, its latest 3 readings for Leases were $13651.0 in Q2 2025, $20324.0 in Q1 2025, and $26898.0 in Q4 2024.